ED

Eric Dai

Bio and Technology

San Francisco, California

Invests in

Stages:

  • Min Investment:

    $500,000.00
  • Max Investment:

    $40,000,000.00
  • Target Investment:

    $20,000,000.00

Work Experience

2025

  • Building

    2025

2023 - 2024

  • Investment Team

    2023 - 2024

    Investing in founders pushing the frontier of tech and life sciences. Fund 1: $350M Fund 2: $500M

2022 - 2023

  • Investment Team

    2022 - 2023

    a16z Bio Fund IV $1.5B Vehicle for Early and Growth Stage Bio+Health Startups

  • PhD Student in Bioengineering, Mauck Lab

    2016 - 2022

    (On Leave, All But Dissertation) Stem Cell Mechanobiology/Engineering with Rob Mauck

  • Teaching Assistant

    2018 - 2021

    TA for MSE 496 Senior Design with Vanessa Chan TA for BE 306 Cellular Engineering with Daniel Hammer

2021 - 2022

  • Venture Associate

    2021 - 2022

    Petri/Pillar VC is a new approach for funding formation-stage startups at the intersection of biology and engineering. Created by the leaders behind iconic companies like Twist Bioscience, Ginkgo Bioworks, Beyond Meat, Exact Sciences, and many more.

2021 - 2022

  • Co-Founder, Co-Managing Director

    2021 - 2022

    Bio Launch supports venture formation from biotechnologies at the University of Pennsylvania, the Wistar Institute, and CHOP. Merged into Nucleate to form Nucleate Philadelphia.

  • Program Coordinator at the DOE Office of Technology Transitions

    2021 - 2022

    Cleantech Commercialization

2021 - 2022

  • Biotech Correspondent

    2021 - 2022

    Reported on leading startups in mRNA engineering, nucleic acid delivery and more

  • Research Assistant

    2011 - 2012

    Particle Physics